• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
XENE

XENE

Xenon Pharmaceuticals Inc.

NASDAQHealthcareBiotechnologyCA

USD53.46

+1.16 (+2.22%)

Rating:C+

Company Profile

CEO

Andrea DiFabio

IPO Date

2014-11-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$52.52

Prev. Close

$52.30

Day Low

$52.30

Day High

$53.86

52W Low

$30.00

52W High

$63.95

Market Cap

$4.22B

Volume

1.70M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

4.7%

Avg Negative

2.6%

Avg Neutral

92.9%

News Feed

Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021

GlobeNewsWire·7/13/2021·↑ positive

Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b “X-TOLE” Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion Leaders

GlobeNewsWire·7/7/2021·↓ negative

Xenon Pharmaceuticals Provides Corporate Update Following its Annual Meeting of Shareholders

GlobeNewsWire·6/3/2021·↓ negative

Xenon Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

GlobeNewsWire·5/31/2021·↑ positive

Xenon Pharmaceuticals Inc. (XENE) CEO Simon Pimstone on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative

Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewsWire·5/11/2021·↑ positive

Xenon Pharmaceuticals to Participate in the Stifel 3rd Annual CNS Day

GlobeNewsWire·3/29/2021·↑ positive

Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewsWire·3/12/2021·↑ positive

Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering

GlobeNewsWire·3/10/2021·↑ positive

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

GlobeNewsWire·3/9/2021·↑ positive